Serac Imaging Systems’ Post

What is the “Impact of #Modular Robotic TME #Training Program on #Perioperative and #Oncological Outcomes in Robotic Rectal Cancer Surgery”? See our new paper on Diseases of the Colon & Rectum‼️ 📈 Robotic surgery is increasingly globally ✋ Structured training programs for robotic colorectal surgery are limited with concerns about surgical outcomes and operating times. ⚔️ We compared perioperative and oncological outcomes of robotic TME between expert consultants and surgical trainees in a #modular surgical training program (5 modules). Tot 177 robotic TME (Group I: n = 80, Group II: n = 97) ⏱️Trainee had longer operative time (225 [197.5-297.5] vs 250 [230-300] minutes, p = 0.004) 📯 No conversion. Comparable R0 resection rate, lymph node harvest, and oncological outcomes between experts and trainees suggesting good quality in oncological resection. 🔎 Robotic TME modular surgical training program #maximizes training experience without significantly affecting the perioperative and oncological outcomes of rectal cancer patients. Link https://lnkd.in/efuiWZpB Jim Khan Patricia Tejedor Portsmouth Hospitals University NHS Trust University of Portsmouth Paper #84

Industry News Alert! 🗞 Medical innovation: Intermountain Health first in nation to use new 3D technology to improve treatment for patients undergoing complex cancer surgery. "Intermountain Health is the first health system in the nation to use a new innovative tool that uses a 3D computer model to guide surgeons during robotic rectal cancer surgery making the procedure more effective and accurate for cancer patients. The new technology, called Iris, converts preoperative MRI images into a 3D model that shows the anatomy and location of the tumor in relation to other organs and structures to enhance the accuracy and effectiveness of the surgical procedure." - Press Release Read More Here. ⬇ https://lnkd.in/gDB7M-7t

A study from Division of Surgical Oncology, Department of Surgery, The University of Texas Southwestern Medical School Medical Center, Dallas, TX suggests 3D Tomosynthesis intraoperative specimen imaging may significantly reduce the need for re-excision surgeries. Researchers observed a lower re-excision rate (5%) in patients receiving 3D Tomosynthesis imaging compared to those with traditional 2D (11%). This promising technology empowers surgeons to achieve clearer margins during the initial surgery, potentially reducing stress, costs, and treatment duration for patients. While further research is needed, this advancement highlights the potential of 3D Tomosynthesis specimen imaging in improving breast cancer surgery outcomes. Here’s the link to the study: https://lnkd.in/gESib8EQ Data Source: Natalia Partain, MD, et al. Differences in Re-excision Rates for Breast-Conserving Surgery Using Intraoperative 2D Versus 3D Tomosynthesis Specimen Radiograph. Ann Surg Oncol 27, 4767–4776 (2020)

I am excited to announce I will be contributing to the MarginDx project as the OCT Lead, part of IHSI at the Beckman Institute! I am happy to join and contribute to such an interdisciplinary and cross-functional technical + clinical team. This is an ARPA-H funded project to improve the management of cancer resection during surgery. It..."combines optical imaging technologies with AI screening tools to ensure, in real time, that tumor tissue and cells are completely removed during surgery" to eliminate the chance of a partial resection - cancerous tissues that are left behind leading to a relapse. More info can be found in these News releases: 1) https://lnkd.in/g5HTyzhT 2) https://lnkd.in/gMXc3Ktr Looking forward to the impact we will have in this domain!

Robotic Surgery Outperforms in Colon Cancer Treatment In a study published by UT Southwestern, robotic surgery has shown significant benefits for most colon cancer patients. The research reveals lower complication rates and shorter hospital stays when compared to laparoscopic techniques. This underscores the positive impact of robotic surgery on outcomes for individuals with colon cancer. To read the full article >>> https://lnkd.in/dVgCU-8X To learn more about Virtual Ports’ “Freedom to Operate” revolution >>> www.virtual-ports.com #RoboticSurgery #ColonCancer #MedicalResearch #HealthcareTechnology #SurgicalInnovation #MedicalAdvancements #PatientOutcomes

ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal Liver Metastasis Resection https://lnkd.in/gPBWn4nD “`html ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal Liver Metastasis Resection The Importance of Margin Assessment in Colorectal Liver Metastasis Resection Colorectal cancer often leads to liver metastasis, and surgery is the best treatment. However, it’s hard to remove the tumor without harming healthy tissue. ICG-Fluorescence Imaging helps solve this problem. What is ICG-Fluorescence Imaging? ICG is a safe dye that, when injected into the bloodstream, can be seen using near-infrared light. This lets surgeons see blood flow and tissue, making it useful in surgeries. The Clinical Trial A study in the Journal of Surgical Oncology involving 50 patients showed that ICG-Fluorescence Imaging accurately identified positive margins in 96% of cases, helping surgeons remove cancer while preserving healthy tissue. Advantages of ICG-Fluorescence Imaging Real-time visualization: Immediate feedback to surgeons during surgery. High accuracy: 96% accuracy rate in identifying positive margins. Minimally invasive: Can be performed using minimally invasive techniques. Cost-effective: A more affordable option compared to other imaging techniques. Limitations and Future Directions Further research is needed due to the small sample size, and it may not be suitable for all patients. However, it has great potential and needs further exploration. Conclusion ICG-Fluorescence Imaging is a valuable tool in improving surgical outcomes and reducing the risk of positive margins. While more research is needed, the results of this study are a step forward in incorporating this technique into routine practice. “` #ClinicalTrials #AIinHealthcare #MedicalAI #HealthTech #DigitalHealth #PatientCareAI #AIResearch #MedicalInnovation #BioTech #AIforGood #HealthcareData #AIinMedicine #PharmaAI #ClinicalData #HealthAI #AIHealthSolutions #PrecisionMedicine #AIandHealth #ClinicalAnalytics #AIDiagnostics

I never cease to be amazed by the level of detail and perfection achieved by 3D reconstruction technologies in the field of complex oncological surgery, now used to help surgical robot for planning and execution. I am sure that the combination of 3D planning with AI elements will become an irreplaceable tool in surgery in near future. #AI #3Dplanning #roboticsurgery #medicalinnovation #oncology

Minimally invasive surgery is changing the game for patients with colorectal cancer. 👏 It means shorter recovery times, less pain and better outcomes. But surgeons need the right tools – and that includes seeing the surgical area with crystal clarity. That's where JUNE MEDICAL comes in. Our Galaxy II retractor and LUX Connect light source are designed to work seamlessly together. This means surgeons can operate more confidently knowing they have amazing visualisation during these intricate procedures. It's this kind of innovation that helps take some of the fear out of surgery for both patients, their families and their care teams. Want to learn more about how we're pushing the boundaries of colorectal cancer surgery? Follow the link to read more! 🔗 https://lnkd.in/gvZrKhqM

Robotic-assisted surgery for gallbladder cancer as effective as traditional surgery . Each year, approximately 2,000 people die annually of gallbladder cancer (GBC) in the U.S., with only one in five cases diagnosed at an early stage. With GBC rated as the first biliary tract cancer and the 17th most deadly cancer worldwide, pressing attention for proper management of disease must be addressed. For patients diagnosed, surgery is the most promising curative treatment. While there has been increasing adoption of minimally invasive surgical techniques in gastrointestinal malignancies, including utilization of laparoscopic and robotic surgery, there are reservations in utilizing minimally invasive surgery for gallbladder cancer. A new study has found that robotic-assisted surgery for GBC is as effective as traditional open and laparoscopic methods, with added benefits in precision and quicker post-operative recovery. #ScienceDailynews #InnovativeResearch #NextGenScience #ExploringFrontiers

🚀 Revolution of Prostate Cancer Surgery: Robotic-Assisted Techniques 🤖 Prostate cancer is the second most common cancer in men worldwide. The proximity to the blood vessels, muscles and nerves makes the surgery complex and it demands extreme precision. Fortunately, today medical technology shifted away from invasive procedures toward minimally invasive techniques, such as laparoscopy and robotic-assisted surgery. Yet, the debate persists: Which approach is the best for prostate cancer treatment—Robotic-Assisted Radical Prostatectomy (RARP) or Laparoscopic Radical Prostatectomy (LRP)? Recent findings published in International Journal of Surgery (10.1097/JS9.0000000000000193), showed some interesting results: not only does RARP demonstrate comparable outcomes to LRP, but it also shows reduced blood loss, shorter hospital stays, and diminished complication rates. Overall RARP is more effective than LRP, also patients and surgeons prefer this advanced technology. However, not all hospital can afford such technologies, this is creating a gap and many radical prostatectomy centers are closing (https://lnkd.in/deQxswKV). Only competition between robot manufacturers can reduce the cost and make RARP accessible to everyone.